Search research articles
Contact Us
Filters
Showing results (21-30 of 89) with videos related to
Page
of 9
Sort By:
Vascular Pharmacology
|
January 20, 2007
Vascular endothelium summary statement III: Cancer prevention and control
Eddie Reed, John Seffrin, Raffaella Giavazzi, et al.
Biochemical and Biophysical Research Communications
|
October 12, 2004
SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway
Xiao-Song Zhong, Jenny Z Zheng, Eddie Reed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2003
Clear cell tumors have higher mRNA levels of ERCC1 and XPB than other histological types of epithelial ovarian cancer
Eddie Reed, Jing Jie Yu, Antony Davies, et al.
Molecular Cancer Therapeutics
|
May 17, 2008
Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1
Rui Gao, Douglas K Price, Tristan Sissung, et al.
Medical Oncology (Northwood, London, England)
|
January 2, 2013
Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells
Qingdi Quentin Li, Rebecca X Lee, Huasheng Liang, et al.
Basic & Clinical Pharmacology & Toxicology
|
May 2, 2012
Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy
Qingdi Quentin Li, Gangduo Wang, Eddie Reed, et al.
Molecular Pharmacology
|
June 24, 2004
9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells
Jing Fang, Zongxian Cao, Yi Charlie Chen, et al.
International Journal of Oncology
|
June 25, 2011
Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells
Anasuya Ray, Erhong Meng, Eddie Reed, et al.
Molecular Cancer
|
May 6, 2004
CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer
Peilin Zhang, Jie Wang, Weiyi Gao, et al.
Molecular Cancer Therapeutics
|
December 19, 2006
Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven
Yutian Wang, Timothy Wiltshire, Jamie Senft, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 89) with videos related to
Sort By:
Page
of 9
Vascular Pharmacology
|
January 20, 2007
Vascular endothelium summary statement III: Cancer prevention and control
Eddie Reed, John Seffrin, Raffaella Giavazzi, et al.
Biochemical and Biophysical Research Communications
|
October 12, 2004
SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway
Xiao-Song Zhong, Jenny Z Zheng, Eddie Reed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2003
Clear cell tumors have higher mRNA levels of ERCC1 and XPB than other histological types of epithelial ovarian cancer
Eddie Reed, Jing Jie Yu, Antony Davies, et al.
Molecular Cancer Therapeutics
|
May 17, 2008
Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1
Rui Gao, Douglas K Price, Tristan Sissung, et al.
Medical Oncology (Northwood, London, England)
|
January 2, 2013
Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells
Qingdi Quentin Li, Rebecca X Lee, Huasheng Liang, et al.
Basic & Clinical Pharmacology & Toxicology
|
May 2, 2012
Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy
Qingdi Quentin Li, Gangduo Wang, Eddie Reed, et al.
Molecular Pharmacology
|
June 24, 2004
9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells
Jing Fang, Zongxian Cao, Yi Charlie Chen, et al.
International Journal of Oncology
|
June 25, 2011
Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells
Anasuya Ray, Erhong Meng, Eddie Reed, et al.
Molecular Cancer
|
May 6, 2004
CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer
Peilin Zhang, Jie Wang, Weiyi Gao, et al.
Molecular Cancer Therapeutics
|
December 19, 2006
Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven
Yutian Wang, Timothy Wiltshire, Jamie Senft, et al.
Page
of 9